

Abbares Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.23 Cr
- Satisfied Charges ₹ 4.47 Cr
- Revenue Growth 36.96%
- Profit Growth 51.29%
- Ebitda 50.63%
- Net Worth 34.64%
- Total Assets 25.10%
About Abbares Pharmaceuticals
Abbares Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 March 2018 (Seven years and one month 10 days old ). Its registered office is in Jodhpur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.23 Cr. The company has closed loans amounting to ₹4.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Bhardwaj, Preksha Bhardwaj, and Seema Bhardwaj serve as directors at the Company.
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909RJ2018PTC060761
- Company No.
060761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Abbares Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajesh Bhardwaj ![]() | Director | 31-Mar-2018 | Current |
Preksha Bhardwaj ![]() | Director | 15-Jun-2019 | Current |
Seema Bhardwaj ![]() | Director | 01-Nov-2021 | Current |
Financial Performance of Abbares Pharmaceuticals.
Abbares Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.96% increase. The company also saw a substantial improvement in profitability, with a 51.29% increase in profit. The company's net worth Soared by an impressive increase of 34.64%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Abbares Pharmaceuticals?
In 2022, Abbares Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Almet Lifesciences Private Limited
Rajesh Bhardwaj is a mutual person
Charges (Loans)
₹42.31 M
₹44.68 M
Charges Breakdown by Lending Institutions
- Others : 4.18 Cr
- Hdfc Bank Limited : 0.05 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Nov 2023 | Others | ₹3.50 Cr | Open |
18 Oct 2022 | Others | ₹6.80 M | Open |
21 Dec 2021 | Hdfc Bank Limited | ₹0.51 M | Open |
30 Sep 2022 | Others | ₹2.97 Cr | Satisfied |
29 Jan 2021 | Hdfc Bank Limited | ₹1.20 Cr | Satisfied |
How Many Employees Work at Abbares Pharmaceuticals?
Unlock and access historical data on people associated with Abbares Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Abbares Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbares Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Abbares Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Abbares Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Abbares Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur.
- Charges
A charge registered on 23 Jan 2019 via Charge ID 100239394 with Others was fully satisfied on 15 Mar 2024.
- Charges
A charge with Others of Rs. 35.00 M registered on 20 Nov 2023 with Charge ID 100844174 was modified on 01 Mar 2024.
- Charges
A charge registered on 30 Sep 2022 via Charge ID 100618580 with Others was fully satisfied on 27 Feb 2024.
- Charges
A charge registered on 29 Jan 2021 via Charge ID 100420556 with Hdfc Bank Limited was fully satisfied on 02 Feb 2024.
Frequently asked questions
What is the Incorporation or founding date of Abbares Pharmaceuticals Private Limited?
Abbares Pharmaceuticals Private Limited was incorporated on 31 Mar 2018.
What is authorized share capital and paid-up capital of Abbares Pharmaceuticals Private Limited?
The authorized share capital of Abbares Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Who are the current board members & directors of Abbares Pharmaceuticals Private Limited?
Currently 3 directors are associated with Abbares Pharmaceuticals Private Limited.
- Rajesh Bhardwaj
- Preksha Bhardwaj
- Seema Bhardwaj
What is the registered address of Abbares Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Abbares Pharmaceuticals Private Limited is Villa No 14 Umaid Haritage, Ratanada India, Jodhpur, Rajasthan, 342011.
What is the corporate identification number (CIN) and company number of Abbares Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Abbares Pharmaceuticals Private Limited is U51909RJ2018PTC060761 and the company number is 060761 as per Ministry of Corporate Affairs (MCA).
What is the official website of Abbares Pharmaceuticals Private Limited?
The Official website of Abbares Pharmaceuticals Private Limited is https://www.abbarespharma.com
What has been the recent revenue trend for Abbares Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Abbares Pharmaceuticals Private Limited has risen by 36.96%.
What change has been observed in the net worth of Abbares Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Abbares Pharmaceuticals Private Limited has experienced an upsurge of 34.64%.
What are the total open charges for Abbares Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Abbares Pharmaceuticals Private Limited amount to ₹ 4.23 Cr.
When was the last Balance Sheet of Abbares Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Abbares Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
SS
Subodh SaxenaDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India